In-Person Access Only | 5.40 CE/CME Credits

All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $25 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.

The University of Tennessee Health Science Center Division of Surgical Oncology is hosting a one-day symposium focused on the multidisciplinary management of gastric and esophageal cancers. The purpose of this activity is to educate healthcare providers on current standards of care as well as evolving new therapies in the treatment of these patients. The symposium will provide a unique opportunity for clinicians involved in the care of gastric and esophageal cancer patients to learn from and interact with leading national faculty in order to increase clinical knowledge, apply new data into practice, and ultimately improve patient outcomes.

Program Chairs

Paxton Dickson, MD | University of Tennessee Health Science Center

Speakers

Saurin Chokshi, MD – The University of Tennessee Health Science Center

Ruitka Mehta, MD, MPH | Weill Cornell Medical Center

Jane Zhao, MD | University of Tennessee Health Science Center

Jeremy Davis, MD | National Institutes of Health

Field Willingham, MD, MPH | Emory University School of Medicine

Naruhiko Ikoma, MD | MD Anderson Cancer Center

Harry Yoon, MD | Mayo Clinic

Conference Agenda
Saturday, November 9, 2024

7:30 AM
Breakfast and Exhibits

8:00 AM
Program Chair Welcome

8:10 AM
Tailoring Neoadjuvant Therapy for Gastroesophageal Junction Cancers Ruitka Mehta, MD, MPH | Weill Cornell Medical Center 

8:40 AM
Harnessing the Immune System for the Treatment of Gastric and Esophageal Cancer Harry Yoon, MD | Mayo Clinic 

9:10 AM
Q&A Panel Discussion Ruitka Mehta, MD, MPH | Weill Cornell Medical Center  Harry Yoon, MD | Mayo Clinic 

9:30 AM
Break and Exhibits

9:50 AM
Surgical Management of Esophageal CancerJane Zhao, MD | University of Tennessee Health Science Center

10:20 AM
Surgical Management of Gastric Cancer Naruhiko Ikoma, MD | MD Anderson Cancer Center

10:50 AM
Advanced Endoscopic Management for Early Stage Gastric and Esophageal Cancers Field Willingham, MD, MPH | Emory University School of Medicine

11:20 AM
Q&A Panel Discussion Jane Zhao, MD | University of Tennessee Health Science Center Naruhiko Ikoma, MD | MD Anderson Cancer Center Field Willingham, MD, MPH| Emory University School of Medicine

11:40 AM
Breakfast and Exhibits

12:00 PM
Non-CME Lunch

1:00 PM
Hereditary Gastric Cancer – Diagnosis, Surveillance, and Surgical Management Jeremy Davis, MD | National Institutes of Health

1:30 PM
Updates on the Management for Metastatic Gastroesophageal Cancer Saurin Chokshi, MD | The University of Tennessee Health Science Center

2:00 PM
Q&A Panel Discussion Jeremy Davis, MD | National Institutes of Health Saurin Chokshi, MD | The University of Tennessee Health Science Center

2:20PM
Break and Exhibits

2:30 PM
Case-Based Multidisciplinary Panel Paxton Dickson, MD (Moderator) | University of Tennessee Health Science Center Ruitka Mehta, MD, MPH | Weill Cornell Medical Center Harry Yoon, MD | Mayo Clinic Jane Zhao, MD | University of Tennessee Health Science Center Naruhiko Ikoma, MD | MD Anderson Cancer Center Field Willingham, MD, MPH | Emory University School of Medicine Jeremy Davis, MD | National Institutes of Health Saurin Chokshi, MD | The University of Tennessee Health Science Center

3:30PM
Closing Remarks

3:35 PM
Networking Reception

Agenda Subject To Change. All times are CST.

• Learning Objectives

  • Understand current and evolving strategies in the neoadjuvant therapy for gastric and esophageal cancer

  • Review and discuss current surgical therapy for gastric and esophageal cancers including incorporation of minimally invasive techniques.

  • Identify the indications and outcomes for endoscopic management in early stage gastroesophageal cancers endoscopic therapy in early stage cancers.

  • Discuss the role of chemotherapy, targeted therapies, and immunotherapy, in the management of patients with gastric and esophageal cancers

• Accreditation Information | 5.40

  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Nurses (ANCC) Credit Designation

  Amedco LLC designates this activity for a maximum of 5.40 ANCC contact hours.

  Physicians (ACCME) Credit Designation

  Amedco LLC designates this live activity for a maximum of 5.40 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

  Amedco LLC designates this activity for a maximum of 5.40 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

• What to Expect | In-Person Learners

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Enduring video content for watching at your leisure

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources

  • Catered meals through-out the program